|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INFLAMMATION AND IMMUNOPHARMACOLOGY
-Stimulated Matrix Metalloproteinase-13 Gene Expression in Human Chondrocytes: Suppression of c-Jun NH2-Terminal Kinase, p38-Mitogen-Activated Protein Kinase and Activating Protein-1
Departments of Orthopedics (S.A., V.M.G.) and Medicine (A.R., A.H., T.M.H.), Case Western Reserve University, Cleveland, Ohio
Cytokine-mediated induction and overexpression of matrix metalloproteinases
(MMPs) is recognized as an important factor in the pathogenesis of arthritis.
Interleukin (IL)-1
is a proinflammatory cytokine that is known to
superinduce the expression and production of MMP-13 in many cell types. Phenyl
N-tert-butylnitrone (PBN), a spin trap agent, inhibited the
IL-1
-induced expression of MMP-13 in human osteoarthritis (OA)
chondrocytes. Down-regulation of MMP-13 expression correlated with the
inhibition of mitogen-activated protein kinase (MAPK) subgroups c-Jun
NH2-terminal kinase (JNK) and p38-MAPK activation, accumulation of
phospho-c-jun, and the DNA binding activity of activating protein-1 (AP-1).
Results of in vitro kinase assays showed that exogenously added PBN completely
blocked the c-Jun phosphorylating activity of JNK. Interestingly, using in
vitro kinase assay, we also found that chondrocyte p38-MAPK phosphorylate
c-Jun and that PBN was not very effective in inhibiting c-Jun phosphorylating
activity of p38-MAPK. In addition, PBN did not block the ATF-2 phosphorylating
activity of p38-MAPK and Elk-1 phosphorylating activity of extracellular
regulated kinase p44/p42 in vitro, indicating that PBN may act selectively to
inhibit the phosphorylation of c-Jun in OA chondrocytes. Together, our results
for the first time demonstrate that PBN suppresses the IL-1
-stimulated
expression of MMP-13 in OA chondrocytes and that this was achieved by
inhibiting the activation of JNK and AP-1. These results suggest that use of
PBN or compounds derived from it may be of potential benefit in inhibiting
signaling events associated with cartilage degradation in arthritis.
Address correspondence to: Dr. Tariq M. Haqqi, Department of Medicine, Division of Rheumatology, Case Western Reserve University School of Medicine, 2109 Adelbert Rd., Cleveland, OH 44106-4946. E-mail: txh5{at}po.cwru.edu
This article has been cited by other articles:
![]() |
M B Goldring, M Otero, K Tsuchimochi, K Ijiri, and Y Li Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii75 - iii82. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Colla, F. Zhan, W. Xiong, X. Wu, H. Xu, O. Stephens, S. Yaccoby, J. Epstein, B. Barlogie, and J. D. Shaughnessy Jr The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells Blood, May 15, 2007; 109(10): 4470 - 4477. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahmed, N. Wang, B. B. Hafeez, V. K. Cheruvu, and T. M. Haqqi Punica granatum L. Extract Inhibits IL-1{beta}-Induced Expression of Matrix Metalloproteinases by Inhibiting the Activation of MAP Kinases and NF-{kappa}B in Human Chondrocytes In Vitro J. Nutr., September 1, 2005; 135(9): 2096 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomita, Y. Kotake, and R. E. Anderson Mechanism of Protection from Light-Induced Retinal Degeneration by the Synthetic Antioxidant Phenyl-N-tert-Butylnitrone Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 427 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahmed, N. Wang, M. Lalonde, V. M. Goldberg, and T. M. Haqqi Green Tea Polyphenol Epigallocatechin-3-gallate (EGCG) Differentially Inhibits Interleukin-1{beta}-Induced Expression of Matrix Metalloproteinase-1 and -13 in Human Chondrocytes J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||